Taewoo Kwon

Title: Taewoo Kwon: Innovator in Oligonucleotide Structures

Introduction

Taewoo Kwon is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of oligonucleotide structures and their applications in various medical treatments. With a total of 2 patents, Kwon's work focuses on enhancing the stability and delivery efficiency of oligonucleotides.

Latest Patents

Kwon's latest patents include two innovative inventions. The first patent is titled "Azo compound, use thereof and method for preparing same." This invention provides a novel azo compound that exhibits a quenching ability for materials that display luminescent phenomena at excited energy levels. The quencher, which comprises this novel azo compound, demonstrates excellent characteristics in a specific wavelength absorption region.

The second patent is "Nanoparticle type oligonucleotide structure having high efficiency and method for preparing same." This invention relates to an oligonucleotide structure where a polymer compound is covalently linked to an oligonucleotide. This linkage improves the in vivo stability and cellular delivery efficiency of the oligonucleotide. The oligonucleotide structure is designed to be a homogeneous material, addressing issues related to polydispersion characteristics. It allows for accurate size adjustments of the double-stranded oligo RNA structure, ensuring that the gene expression regulation function remains intact. This innovative oligonucleotide structure can serve as a novel delivery system for treating cancers and infectious diseases.

Career Highlights

Taewoo Kwon is currently associated with Bioneer Corporation, where he continues to advance his research and development efforts. His work at Bioneer Corporation has positioned him as a key player in the field of biotechnology and oligonucleotide research.

Collaborations

Kwon collaborates with notable colleagues, including Sun Gi Kim and Han Oh Park. Their combined expertise contributes to the innovative projects at Bioneer Corporation.

Conclusion

Taewoo Kwon's contributions to the field of oligonucleotide structures and his innovative patents highlight his role as a leading inventor in biotechnology. His work not only enhances the understanding of oligonucleotide delivery systems but also paves the way for potential treatments for various diseases.